LINCOLN NATIONAL CORP - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$2,131
-46.7%
11,215
+8.7%
0.00%
Q2 2022$4,000
-69.2%
10,3150.0%0.00%
Q1 2022$13,0000.0%10,3150.0%0.00%
Q4 2021$13,000
-40.9%
10,315
+3.2%
0.00%
-100.0%
Q4 2019$22,00010,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 277,177$915,0000.11%
WEBSTER BANK, N. A. 50,000$165,0000.02%
Brown Advisory Securities, LLC 28,000$92,0000.02%
SIMPLEX TRADING, LLC 50,804$167,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$83,0000.00%
GROUP ONE TRADING, L.P. 89,372$295,0000.00%
Squarepoint Ops LLC 10,194$34,0000.00%
Tower Research Capital LLC (TRC) 1,851$6,0000.00%
WOLVERINE TRADING, LLC 58,500$193,0000.00%
WOLVERINE TRADING, LLC 61,690$204,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders